Lobbying Update: $20,000 of LEGGETT & PLATT INC. lobbying was just disclosed

$20,000 of LEGGETT & PLATT INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to corporate and international tax. Issues related IRC sections 11, 951A, 174, 41, 168(k), and 163(j). (H.R. 7024 and H.R. 2673)"

You can find more data on corporate lobbying on Quiver Quantitative.

LEG Congressional Stock Trading

Members of Congress have traded $LEG stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $LEG stock by members of Congress over the last 6 months:

• SENATOR GARY C. PETERS sold up to $15,000 on 10/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

LEG Hedge Fund Activity

We have seen 155 institutional investors add shares of LEG stock to their portfolio, and 191 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. removed 2,385,858 shares (-12.0%) from their portfolio in Q3 2024, for an estimated $32,495,385
• SCOPUS ASSET MANAGEMENT, L.P. added 1,725,000 shares (+inf%) to their portfolio in Q3 2024, for an estimated $23,494,500
• D. E. SHAW & CO., INC. removed 1,170,097 shares (-35.5%) from their portfolio in Q3 2024, for an estimated $15,936,721
• WELLINGTON MANAGEMENT GROUP LLP added 1,155,286 shares (+inf%) to their portfolio in Q3 2024, for an estimated $15,734,995
• INVENOMIC CAPITAL MANAGEMENT LP added 731,132 shares (+384.1%) to their portfolio in Q3 2024, for an estimated $9,958,017
• PACER ADVISORS, INC. removed 708,854 shares (-5.0%) from their portfolio in Q3 2024, for an estimated $9,654,591
• FMR LLC added 672,290 shares (+3264.5%) to their portfolio in Q3 2024, for an estimated $9,156,589

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.